OverviewSuggest Edit

Oyster Point Pharma is a clinical-stage pharmaceutical company. The company focuses on the discovery, development, and commercialization of novel therapies to treat ocular surface disease.

TypePublic
Founded2015
HQPrinceton, US
Websiteoysterpointrx.com

Latest Updates

Employees (est.) (Dec 2019)30(+67%)
Share Price (Aug 2020)$25.5 (-5%)
Cybersecurity ratingAMore

Key People/Management at Oyster Point Pharma

Jeffrey Nau

Jeffrey Nau

President and Chief Executive Officer
Daniel Lochner

Daniel Lochner

Chief Financial Officer
John Snisarenko

John Snisarenko

Chief Commercial Officer
Loni da Silva

Loni da Silva

Vice President of Regulatory Affairs
Dawn Pruitt Koffler

Dawn Pruitt Koffler

Vice President of Marketing
George Donato

George Donato

Vice President of CMC
Show more

Oyster Point Pharma Office Locations

Oyster Point Pharma has an office in Princeton
Princeton, US (HQ)
202 Carnegie Center Dr #109Princeton
Show all (1)

Oyster Point Pharma Financials and Metrics

Oyster Point Pharma Revenue

USD

Net income (Q2, 2020)

(15.5m)

EBIT (Q2, 2020)

(15.5m)

Market capitalization (6-Aug-2020)

655.7m

Closing stock price (6-Aug-2020)

25.5

Cash (30-Jun-2020)

226.7m

EV

429.3m
Oyster Point Pharma's current market capitalization is $655.7 m.
Annual
USDFY, 2017FY, 2018FY, 2019

General and administrative expense

2.1m3.0m13.7m

R&D expense

3.6m13.8m33.6m

Operating expense total

5.7m16.7m47.3m

EBIT

(5.7m)(16.7m)(47.3m)
Half Year
USDH1, 2018H1, 2019

General and administrative expense

1.4m4.7m

R&D expense

4.6m10.5m

Operating expense total

6.0m15.2m

EBIT

(6.0m)(15.2m)
Quarterly
USDQ3, 2019Q1, 2020Q2, 2020

General and administrative expense

3.8m5.6m6.9m

R&D expense

8.1m11.3m8.6m

Operating expense total

11.9m16.9m15.5m

EBIT

(11.9m)(16.9m)(15.5m)
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

22.3m5.2m139.1m

Prepaid Expenses

863.0k390.0k3.0m

Current Assets

23.2m5.6m142.2m

PP&E

181.0k
Quarterly
USDQ2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

83.4m72.3m128.6m226.7m

Prepaid Expenses

4.1m4.6m2.4m1.8m

Current Assets

87.4m76.9m131.0m228.6m

PP&E

263.0k483.0k
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

(6.6m)(16.5m)(45.7m)

Depreciation and Amortization

19.0k

Accounts Payable

61.0k44.0k38.0k

Cash From Operating Activities

(4.7m)(17.1m)(40.8m)
Quarterly
USDQ2, 2018Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(5.9m)(14.5m)(26.0m)(16.5m)(32.0m)

Depreciation and Amortization

17.0k40.0k

Accounts Payable

1.5m1.6m1.2m6.4m3.3m

Cash From Operating Activities

(6.5m)(14.5m)(24.3m)(10.4m)(25.1m)
USDFY, 2017

Financial Leverage

1.1 x
Show all financial metrics

Oyster Point Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset

A

98/100

SecurityScorecard logo

Oyster Point Pharma Online and Social Media Presence

Embed Graph

Oyster Point Pharma News and Updates

Oyster Point Pharma Reports Second Quarter 2020 Financial Results and Recent Business Highlights

PRINCETON, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, announced its financial r…

Oyster Point Pharma Blogs

Oyster Point Announces Positive Results from Two Separate Phase 2b Clinical Trials of the Company’s Investigational Treatments for Dry Eye Disease

–Two Lead Clinical Candidates are Delivered as a Nasal Spray to Stimulate the Trigeminal Parasympathetic Pathway to Promote Natural Tear Film Production– PRINCETON, New Jersey – October 24, 2018 – Oyster Point Pharma, Inc., today announced results from the ONSET and RAINIER studies, two separate Pha…
Show more

Oyster Point Pharma Frequently Asked Questions

  • When was Oyster Point Pharma founded?

    Oyster Point Pharma was founded in 2015.

  • Who are Oyster Point Pharma key executives?

    Oyster Point Pharma's key executives are Jeffrey Nau, Daniel Lochner and John Snisarenko.

  • How many employees does Oyster Point Pharma have?

    Oyster Point Pharma has 30 employees.

  • Who are Oyster Point Pharma competitors?

    Competitors of Oyster Point Pharma include Mirum Pharmaceuticals, Myonexus and MCRC.

  • Where is Oyster Point Pharma headquarters?

    Oyster Point Pharma headquarters is located at 202 Carnegie Center Dr #109Princeton, Princeton.

  • Where are Oyster Point Pharma offices?

    Oyster Point Pharma has an office in Princeton.

  • How many offices does Oyster Point Pharma have?

    Oyster Point Pharma has 1 office.